Jeffrey Lawrence Schwartz Spring Works Therapeutics, Inc. (SWTX) insider trading activity

Jeffrey Lawrence Schwartz is Director of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 10,572 shares of SWTX, which is worth approximately $409,665. The most recent transaction as insider was on May 24, 2023, when has been sold 4,648 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.6K

0% 3M change

0% 12M change

Total Value Held $409,665

Jeffrey Lawrence Schwartz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 24 2023	BUY Grant, award, or other acquisition	-	4,648 Added 30.54%	10,572 Common Stock
May 19 2022	BUY Grant, award, or other acquisition	-	4,818 Added 44.85%	5,924 Common Stock
May 20 2021	BUY Grant, award, or other acquisition	-	1,106 Added 50.0%	1,106 Common Stock

Also insider at

BLSA

BCLS Acquisition Corp. Financial Services

Chief Executive Officer

RPID

RAPID MICRO BIOSYSTEMS, INC. Healthcare

JLS